Posted on by

In surprise decision, US approves muscular dystrophy drug – The Associated Press

  1. In surprise decision, US approves muscular dystrophy drug  The Associated Press
  2. Sarepta’s surprise FDA approval for rare disease drug excites investors  MarketWatch
  3. FDA OKs Golodirsen (Vyondys 53) for Duchenne Muscular Dystrophy  Medscape
  4. Amarin Stock, CRH, ServiceNow, StoneCo, Adobe And More Added To IBD Watchlists  Investor’s Business Daily
  5. Chris Garabedian on Sarepta’s legacy and Biogen’s future at the FDA  STAT
  6. View full coverage on Google News